When psychedelic therapies begin to gain regulatory approval, they will need to be incorporated into the medical billing and coding system in a way that ensures...
Over 100 academics, psychologists, anthropologists and activists have signed a manifesto launched by the Chacruna Institute for Psychedelic Plant Medicines calling for an end to police...
In two letters seen by Psychedelic Health, a cross-party group of MEPs has expressed concern over the lack of progress with the medical use of psychedelics...
In what marks an important development for Europe, a number of EU bodies have published a joint commentary in the world-leading medical journal, The Lancet, acknowledging...
For the next two weeks, a digital poster campaign will be featured in London asking the UK public “Could magic mushrooms be medicine?”.
In a groundbreaking development, Australia is to reclassify psilocybin and MDMA to enable prescribing by authorised psychiatrists.
The Psychedelic Access and European Alliance (PAREA) has launched an appeal to European Union institutions and Member States for psychedelic-assisted therapies in Europe.
Canadian non-profit TheraPsil has announced that patients and medical professionals from across Canada will be reaching out to Parliamentarians to raise awareness of the medical benefits...
Colorado has voted to pass the Natural Medicine Health Act (Proposition 122) by 51.4%, which will see the decriminalisation and regulation of the use of psychedelic medicines.
Will Alberta’s new regulatory framework for the delivery of psychedelic therapies pave the way for their integration into the healthcare system, or will it create a...